BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23280341)

  • 1. Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
    Collins GS; Altman DG
    Cancer Epidemiol; 2013 Apr; 37(2):115-20. PubMed ID: 23280341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
    Collins GS; Altman DG
    Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
    Collins GS; Altman DG
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):423-9. PubMed ID: 23121234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal).
    Collins GS; Altman DG
    Br J Cancer; 2012 Jul; 107(2):260-5. PubMed ID: 22699822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).
    Collins GS; Altman DG
    Br J Gen Pract; 2013 Sep; 63(614):e636-42. PubMed ID: 23998844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients with suspected renal tract cancer in primary care: derivation and validation of an algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2012 Apr; 62(597):e251-60. PubMed ID: 22520912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.
    Collins GS; Altman DG
    Heart; 2012 Jul; 98(14):1091-7. PubMed ID: 22689714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
    Briggs SEW; Law P; East JE; Wordsworth S; Dunlop M; Houlston R; Hippisley-Cox J; Tomlinson I
    BMJ; 2022 Nov; 379():e071707. PubMed ID: 36351667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Mar; 5(3):e007825. PubMed ID: 25783428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
    Collins GS; Altman DG
    Diabet Med; 2011 May; 28(5):599-607. PubMed ID: 21480970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2013 Jan; 63(606):e11-21. PubMed ID: 23336450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
    Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
    Collins GS; Mallett S; Altman DG
    BMJ; 2011 Jun; 342():d3651. PubMed ID: 21697214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and risk factors to identify men with suspected cancer in primary care: derivation and validation of an algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2013 Jan; 63(606):e1-10. PubMed ID: 23336443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2011 Nov; 61(592):e707-14. PubMed ID: 22054334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier.
    Iyen-Omofoman B; Tata LJ; Baldwin DR; Smith CJ; Hubbard RB
    Thorax; 2013 May; 68(5):451-9. PubMed ID: 23321602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm.
    Hippisley-Cox J; Coupland C
    BMJ; 2011 Jan; 344():d8009. PubMed ID: 22217630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm.
    Hippisley-Cox J; Coupland C
    Br J Gen Pract; 2011 Nov; 61(592):e715-23. PubMed ID: 22054335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction.
    Barra S; Almeida I; Caetano F; Providência R; Paiva L; Dinis P; Leitão Marques A
    Thromb Res; 2013 Aug; 132(2):293-9. PubMed ID: 23928474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.